Remuzzi G - Search Results

1

Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial.

Gotti E, Perico N, Gaspari F, Cattaneo D, Lesti MD, Ruggenenti P, Segoloni G, Salvadori M, Rigotti P, Valente U, Donati D, Sandrini S, Federico S, Sparacino V, Mourad G, Bosmans JL, Dimitrov BD, Iordache BE, Remuzzi G. Gotti E, et al. Among authors: remuzzi g. Transplant Proc. 2005 Jun;37(5):2037-40. doi: 10.1016/j.transproceed.2005.03.096. Transplant Proc. 2005. PMID: 15964332 Clinical Trial.

2

Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation.

Perico N, Ruggenenti P, Gaspari F, Mosconi L, Benigni A, Amuchastegui CS, Gasparini F, Remuzzi G. Perico N, et al. Among authors: remuzzi g. Transplantation. 1992 Jul;54(1):56-60. doi: 10.1097/00007890-199207000-00009. Transplantation. 1992. PMID: 1631945

3

Cyclosporine-induced renal dysfunction in experimental animals and humans.

Remuzzi G, Perico N. Remuzzi G, et al. Kidney Int Suppl. 1995 Dec;52:S70-4. Kidney Int Suppl. 1995. PMID: 8587288 Review.

4

Recovery of blood mononuclear cell calcineurin activity segregates two populations of renal transplant patients with different sensitivities to cyclosporine inhibition.

Piccinini G, Gaspari F, Signorini O, Remuzzi G, Perico N. Piccinini G, et al. Among authors: remuzzi g. Transplantation. 1996 May 27;61(10):1526-31. doi: 10.1097/00007890-199605270-00020. Transplantation. 1996. PMID: 8633383

5

A logistic-regression model provides novel guidelines to maximize the anti-acute rejection properties of cyclosporine with a minimum of toxicity.

Perna A, Gotti E, de Bernardis E, Perico N, Remuzzi G. Perna A, et al. Among authors: remuzzi g. J Am Soc Nephrol. 1996 May;7(5):786-91. doi: 10.1681/ASN.V75786. J Am Soc Nephrol. 1996. PMID: 8738815

6

Sequential monitoring of urine-soluble interleukin 2 receptor and interleukin 6 predicts acute rejection of human renal allografts before clinical or laboratory signs of renal dysfunction.

Casiraghi F, Ruggenenti P, Noris M, Locatelli G, Perico N, Perna A, Remuzzi G. Casiraghi F, et al. Among authors: remuzzi g. Transplantation. 1997 May 27;63(10):1508-14. doi: 10.1097/00007890-199705270-00023. Transplantation. 1997. PMID: 9175818

7

Prevention of transplant rejection: current treatment guidelines and future developments.

Perico N, Remuzzi G. Perico N, et al. Among authors: remuzzi g. Drugs. 1997 Oct;54(4):533-70. doi: 10.2165/00003495-199754040-00003. Drugs. 1997. PMID: 9339960 Review.

8

Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients.

Gaspari F, Anedda MF, Signorini O, Amuchastegui SC, Perico N, Remuzzi G. Gaspari F, et al. Among authors: remuzzi g. Transplant Proc. 1998 Aug;30(5):1654-5. doi: 10.1016/s0041-1345(98)00378-9. Transplant Proc. 1998. PMID: 9723229 Clinical Trial. No abstract available.

9

Optimization of cyclosporine therapy in kidney transplantation.

Remuzzi G, Perico N, Gaspari F. Remuzzi G, et al. Transplant Proc. 1998 Aug;30(5):1673-6. doi: 10.1016/s0041-1345(98)00387-x. Transplant Proc. 1998. PMID: 9723238 Review. No abstract available.

10

How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?

Gaspari F, Perico N, Pisoni R, Anedda MF, Signorini O, Caruso R, Gotti E, Remuzzi G. Gaspari F, et al. Among authors: remuzzi g. Clin Transplant. 1998 Oct;12(5):379-90. Clin Transplant. 1998. PMID: 9787945 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,536 results

Search Page

Filters